Intellia Therapeutics shares owned by Frazier Life Sciences Management
Quarter-by-quarter ownership of Intellia Therapeutics (NTLA) shares owned by Frazier Life Sciences Management
from 13F filings
Historical chart of Frazier Life Sciences Management investment in Intellia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Intellia Therapeutics held by Frazier Life Sciences Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Intellia Therapeutics by Frazier Life Sciences Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $6.2M | 204k | 30.49 |
| 2023-09-30 | $6.4M | 204k | 31.62 |
| 2023-06-30 | $8.3M | 204k | 40.78 |
| 2023-03-31 | $7.6M | 204k | 37.27 |
| 2022-12-31 | $7.1M | 204k | 34.89 |
| 2022-09-30 | $11M | 204k | 55.96 |
| 2022-06-30 | $11M | 204k | 51.76 |
| 2022-03-31 | $15M | 204k | 72.67 |
More positions owned by Frazier Life Sciences Management
View all positions for Frazier Life Sciences Management